vs
GE医疗（CCRN）与Mativ Holdings, Inc.（MATV）财务数据对比。点击上方公司名可切换其他公司
Mativ Holdings, Inc.的季度营收约是GE医疗的2.0倍（$463.1M vs $236.8M），Mativ Holdings, Inc.净利率更高（21.8% vs -35.0%，领先56.8%），Mativ Holdings, Inc.同比增速更快（1.0% vs -23.6%），GE医疗自由现金流更多（$16.1M vs $8.0M），过去两年Mativ Holdings, Inc.的营收复合增速更高（-3.8% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
CCRN vs MATV — 直观对比
营收规模更大
MATV
是对方的2.0倍
$236.8M
营收增速更快
MATV
高出24.6%
-23.6%
净利率更高
MATV
高出56.8%
-35.0%
自由现金流更多
CCRN
多$8.1M
$8.0M
两年增速更快
MATV
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $463.1M |
| 净利润 | $-82.9M | $100.8M |
| 毛利率 | — | 18.8% |
| 营业利润率 | -30.2% | 2.2% |
| 净利率 | -35.0% | 21.8% |
| 营收同比 | -23.6% | 1.0% |
| 净利润同比 | -2109.7% | 6620.0% |
| 每股收益（稀释后） | $-2.56 | $1.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNMATV
| Q4 25 | $236.8M | $463.1M | ||
| Q3 25 | $250.1M | $513.7M | ||
| Q2 25 | $274.1M | $525.4M | ||
| Q1 25 | $293.4M | $484.8M | ||
| Q4 24 | $309.9M | $458.6M | ||
| Q3 24 | $315.1M | $498.5M | ||
| Q2 24 | $339.8M | $523.8M | ||
| Q1 24 | $379.2M | $500.2M |
净利润CCRNMATV
| Q4 25 | $-82.9M | $100.8M | ||
| Q3 25 | $-4.8M | $-3.2M | ||
| Q2 25 | $-6.7M | $-9.5M | ||
| Q1 25 | $-490.0K | $-425.5M | ||
| Q4 24 | $-3.8M | $1.5M | ||
| Q3 24 | $2.6M | $-20.8M | ||
| Q2 24 | $-16.1M | $-1.4M | ||
| Q1 24 | $2.7M | $-28.0M |
毛利率CCRNMATV
| Q4 25 | — | 18.8% | ||
| Q3 25 | 20.4% | 19.3% | ||
| Q2 25 | 20.4% | 19.7% | ||
| Q1 25 | 20.0% | 15.0% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | 20.4% | 18.8% | ||
| Q2 24 | 20.8% | 20.8% | ||
| Q1 24 | 20.4% | 16.8% |
营业利润率CCRNMATV
| Q4 25 | -30.2% | 2.2% | ||
| Q3 25 | -2.4% | 3.1% | ||
| Q2 25 | -2.1% | 3.8% | ||
| Q1 25 | -0.3% | -88.8% | ||
| Q4 24 | -1.1% | 0.6% | ||
| Q3 24 | 0.9% | 1.4% | ||
| Q2 24 | -5.7% | 2.0% | ||
| Q1 24 | 0.8% | -2.8% |
净利率CCRNMATV
| Q4 25 | -35.0% | 21.8% | ||
| Q3 25 | -1.9% | -0.6% | ||
| Q2 25 | -2.4% | -1.8% | ||
| Q1 25 | -0.2% | -87.8% | ||
| Q4 24 | -1.2% | 0.3% | ||
| Q3 24 | 0.8% | -4.2% | ||
| Q2 24 | -4.7% | -0.3% | ||
| Q1 24 | 0.7% | -5.6% |
每股收益（稀释后）CCRNMATV
| Q4 25 | $-2.56 | $1.87 | ||
| Q3 25 | $-0.15 | $-0.06 | ||
| Q2 25 | $-0.20 | $-0.18 | ||
| Q1 25 | $-0.02 | $-7.82 | ||
| Q4 24 | $-0.13 | $0.03 | ||
| Q3 24 | $0.08 | $-0.38 | ||
| Q2 24 | $-0.47 | $-0.03 | ||
| Q1 24 | $0.08 | $-0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $84.2M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $322.8M | $498.7M |
| 总资产 | $449.0M | $2.1B |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势，按日历期对齐
现金及短期投资CCRNMATV
| Q4 25 | $108.7M | $84.2M | ||
| Q3 25 | $99.1M | $97.1M | ||
| Q2 25 | $81.2M | $95.6M | ||
| Q1 25 | $80.7M | $84.0M | ||
| Q4 24 | $81.6M | $94.3M | ||
| Q3 24 | $64.0M | $162.2M | ||
| Q2 24 | $69.6M | $133.4M | ||
| Q1 24 | $5.2M | $128.9M |
总债务CCRNMATV
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
股东权益CCRNMATV
| Q4 25 | $322.8M | $498.7M | ||
| Q3 25 | $408.1M | $397.4M | ||
| Q2 25 | $412.2M | $416.6M | ||
| Q1 25 | $418.2M | $428.2M | ||
| Q4 24 | $419.0M | $858.5M | ||
| Q3 24 | $424.7M | $882.3M | ||
| Q2 24 | $433.3M | $898.0M | ||
| Q1 24 | $462.4M | $906.9M |
总资产CCRNMATV
| Q4 25 | $449.0M | $2.1B | ||
| Q3 25 | $538.2M | $2.0B | ||
| Q2 25 | $553.8M | $2.1B | ||
| Q1 25 | $576.2M | $2.1B | ||
| Q4 24 | $589.3M | $2.4B | ||
| Q3 24 | $597.4M | $2.6B | ||
| Q2 24 | $602.9M | $2.6B | ||
| Q1 24 | $648.4M | $2.7B |
负债/权益比CCRNMATV
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 2.63× | ||
| Q2 25 | — | 2.66× | ||
| Q1 25 | — | 2.67× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | 1.30× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $8.0M |
| 自由现金流率自由现金流/营收 | 6.8% | 1.7% |
| 资本支出强度资本支出/营收 | 0.9% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.19× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $93.8M |
8季度趋势，按日历期对齐
经营现金流CCRNMATV
| Q4 25 | $18.2M | $19.3M | ||
| Q3 25 | $20.1M | $72.8M | ||
| Q2 25 | $4.2M | $57.6M | ||
| Q1 25 | $5.7M | $-15.9M | ||
| Q4 24 | $24.2M | $24.1M | ||
| Q3 24 | $7.5M | $37.6M | ||
| Q2 24 | $82.4M | $46.1M | ||
| Q1 24 | $6.0M | $-13.0M |
自由现金流CCRNMATV
| Q4 25 | $16.1M | $8.0M | ||
| Q3 25 | $17.9M | $66.7M | ||
| Q2 25 | $2.3M | $48.9M | ||
| Q1 25 | $3.8M | $-29.8M | ||
| Q4 24 | $21.7M | $2.0M | ||
| Q3 24 | $6.3M | $25.5M | ||
| Q2 24 | $79.6M | $37.4M | ||
| Q1 24 | $3.8M | $-25.1M |
自由现金流率CCRNMATV
| Q4 25 | 6.8% | 1.7% | ||
| Q3 25 | 7.2% | 13.0% | ||
| Q2 25 | 0.8% | 9.3% | ||
| Q1 25 | 1.3% | -6.1% | ||
| Q4 24 | 7.0% | 0.4% | ||
| Q3 24 | 2.0% | 5.1% | ||
| Q2 24 | 23.4% | 7.1% | ||
| Q1 24 | 1.0% | -5.0% |
资本支出强度CCRNMATV
| Q4 25 | 0.9% | 2.4% | ||
| Q3 25 | 0.9% | 1.2% | ||
| Q2 25 | 0.7% | 1.7% | ||
| Q1 25 | 0.6% | 2.9% | ||
| Q4 24 | 0.8% | 4.8% | ||
| Q3 24 | 0.4% | 2.4% | ||
| Q2 24 | 0.8% | 1.7% | ||
| Q1 24 | 0.6% | 2.4% |
现金转化率CCRNMATV
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 16.07× | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
